Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1998
11/05/1998CA2289253A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
11/05/1998CA2289040A1 Nerve growth factor as a vaccine adjuvant
11/05/1998CA2288853A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds
11/05/1998CA2288433A1 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998CA2288337A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
11/05/1998CA2288211A1 Antigenic composition and method of detection for helicobacter pylori
11/05/1998CA2288138A1 Compounds and compositions for delivering active agents
11/05/1998CA2287976A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant
11/05/1998CA2287916A1 Polypeptides associated with activator receptors and their biological applications
11/05/1998CA2258277A1 Characterization of granulocytic ehrlichia and methods of use
11/05/1998CA2258266A1 Nucleic acids, proteins, and methods of use of granulocytic ehrlichia
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875574A2 Live attenuated bacteria of the species Actinobacillus pleuropneumoniae
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0874992A1 Compounds and methods for the detection and prevention of t. cruzi infection
11/04/1998EP0874905A1 Novel tcts response regulator of staphylococcus aureus
11/04/1998EP0874902A2 Compositions and methods for the treatment and diagnosis of breast cancer
11/04/1998EP0874637A1 Therapeutic applications of t-bam (cd40l) technology to treat inflammatory kidney diseases
11/04/1998EP0696270B1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/04/1998EP0656950B1 Tat-derived transport polypeptides
11/04/1998EP0602144B1 Dna sequences encoding gelonin polypeptide
11/04/1998EP0564477B1 Fragments of the env protein of the feline immunodeficiency virus, antibodies and their applications in diagnosis
11/04/1998EP0554446B1 Monoclonal antibodies useful in therapy of HIV-1 infection
11/04/1998EP0486622B1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium
11/04/1998CN1198185A Detection, prevention and treatment of papillomatous digital dermatitis
11/04/1998CN1198101A Compositions and their uses
11/04/1998CN1198099A Acellular pertussis vaccines and method of preparation thereof
11/04/1998CN1198098A Use of muteins of wild-type cytokines as immunogens
11/04/1998CN1040540C Anthracene ring antibiotic thioether conjugates, its prepn. and pharmaceutical composition containing same
11/03/1998US5831068 Method to increase the density of antigen on antigen presenting cells
11/03/1998US5831064 Kaposi's sarcoma-associated herpes virus (KSHV) interferon consensus sequence binding protein (ICSBP) and uses thereof
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831031 Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5831009 Protein phosphotyrosine phosphatases PTP-D1
11/03/1998US5830999 Carboxylic ligands, hexamers
11/03/1998US5830995 Fanphiregulins: a family of heparin-binding epithelial cell growth factors
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
11/03/1998US5830876 Genetic immunization
11/03/1998US5830858 Neurotrophic factor
11/03/1998US5830768 Carbamazepine derivatives used in particle reagents
11/03/1998US5830759 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/03/1998US5830758 Binding to lymphocytes
11/03/1998US5830753 Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
11/03/1998US5830721 Libraries of peptides, antibodies
11/03/1998US5830710 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
11/03/1998US5830703 DNA encoding adrenomedullin
11/03/1998US5830702 Live vaccine that induces cell mediated immunity
11/03/1998US5830691 Protein of hepatitis c virus production system suitable for preparing a vaccine and as a diagnostic reagent
11/03/1998US5830667 Human P450 IID6 cytochrome-derived peptide fragments, anti-peptide fragment antibodies, applications thereof in the diagnosis of autoimmune hepatitis
11/03/1998US5830660 Tumorigenesis protein
11/03/1998US5830646 Diagnostic method
11/03/1998US5830641 Nucleotide sequence used as hybrid probe
11/03/1998US5830634 Aids diagnosis, screening blood doners
11/03/1998US5830479 Active immunization using a siderophore receptor protein
11/03/1998US5830477 Vaccine against rabies and process for preparation thereof
11/03/1998US5830476 Active induction or passive immunization of anti-Gp48 antibodies and isolated gp48 protein
11/03/1998US5830475 Recombinant mycobacterial vaccines
11/03/1998US5830473 Antibodies against T cells as therapeutics
11/03/1998US5830472 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
11/03/1998US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998US5830464 Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830458 Method for destroying a diseased human cell
11/03/1998US5830457 Recombinant beta-lactamase, usable as carrier molecule in immunogenic compositions
11/03/1998US5830448 Compositions and methods for the treatment of tumors
11/03/1998CA1340110C Carcinoma-associated antigens, and antibodies which recognize these antigens
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998WO1998048026A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998WO1998048022A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
10/29/1998WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998WO1998048000A2 A cell strain with activated anti-cancer cytotoxic activity
10/29/1998WO1998047918A1 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/29/1998WO1998047915A1 Neoglycoproteins
10/29/1998WO1998047530A2 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
10/29/1998WO1998047529A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
10/29/1998WO1998047480A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998WO1998035045A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/29/1998WO1998033470A3 Substituted perylenequinones for use in photodynamic therapy
10/29/1998WO1998027999A3 Anti-allergenic compounds for the treatment of immune diseases containing haptenized antigen antibody complexes
10/29/1998WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998WO1998021233A3 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/29/1998CA2288267A1 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
10/29/1998CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998CA2286210A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998CA2284729A1 Neoglycoproteins
10/29/1998CA2283755A1 Human complement c3-degrading proteinase from streptococcus pneumoniae
1 ... 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 ... 1823